Did you know that #Hyperkalemia is increasing in pts w/ #HF? Join @CanHFSociety & @JonathanHowlet6 on May 27 for a virtual event with Patrick Rossignol MD & Ileana Piña MD about the latest data on treating hyperkalemia without discontinuing RAASi: https://t.co/IEzBnc8EGa https://t.co/sUEGuvJ6L0

? of @SCC_CCS #EDI survey - @CachNetwork @canSCMR ?. Can you catch them? ?‍♀️ ?‍♂️ @CHRS_SCR @CanHFSociety @CSEchoCa @CSCS_SCCC et al? 4 days to go! Complete by end of May 24 ?️https://t.co/LBNaR96Fqz https://t.co/7vOaGKAxcI

On another note #CONNECTHF @_adevore: cluster-randomized trial to ✔ effect of ?and post-DC #QI intervention?usual care in the US ?No diff. in #HF re:H/death or comp. quality score ‼️ Abysmal rates of ACEI/ARB/ARNI, BB, and MRA ?This is where groundwork is needed #ACC21 https://t.co/ODOaFkLLiO

??Let's do our part members and complete the @SCC_CCS EDI survey!! It only takes a few minutes! @AniqueDucharme @JustinEzekowitz @PikeRodolfo @ShelleyZieroth @lizswiggum @JonathanHowlet6 @DktrV @GordFogg @Derek_Leong_RPh @Ricky_Turgeon @HaythamSharar https://t.co/9kUSfV4YPo https://t.co/TPYdEj3SMm

@DLBHATTMD presents pooled results of #SOLOIST #SCORED: SGLT1/2i #sotagliflozin in #HF #HFrEF #HFpEF #ACC21 ?Total CV Death,? & Urgent HF Visit HR 0.72 (0.63-0.82) ?Driven by ? & Urgent HF Visit ?In on-treatment analysis: ?CV Death ⚠ Term. early 2/2 COVID https://t.co/esWeLYClDh

#ACC21 #SOLOIST TRIAL Sotagliflozin Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the SOLOIST-WHF Trial ?#SGLT2i: we have come a long way baby! #SOLOIST examine DM & HF and effect on hospitalizations ?1/3 women #morewomenplease https://t.co/PxZpj0rTC4

REHAB-HF: Diverse, older pop w acute HF regardless of EF (~73 yo, >50% women, >45% Black pts, 53% HFpEF): Early, multi-domain, progressive rehab intervention improved physical function, frailty, QOL, & depression. Need phase 3 trial #ACC21 #cardiotwitter https://t.co/GXDYBFWb0i https://t.co/wx8FvUYUA7

IMPORTANT: May 12 ? of @SCC_CCS EDI survey responses: TOP: @SCMRorg 47%, CACH 33%, CNCT 27% ?! @CHRS_SCR @CanHFSociety @CSEchoCa @CSCS_SCCC can you keep up? Help ? & participate! Respond by May 22 ?! ? @Cardio_Girl @HeartDocSharon @ShelleyZieroth https://t.co/LBNaR96Fqz

@SCC_CCS @SCC_CCS_Trainee @CHRS_SCR @CSEchoCa @CanHFSociety HEY MEMBERS: Have your say on EDI in CV care! ??? to CNCT, @CachNetwork @canSCMR !! ♥️COME ON @CHRS_SCR @CanHFSociety @CSEchoCa et al!! @AndrewKrahnMD @Cardio_Girl @ShelleyZieroth @HeartDocSharon @gurm33t ??????♥️ https://t.co/btM3h6yHx0

New #ACC21 SimPub in @JACCJournals from #TRANSLATEHF collab led by @RBPatelMD Strong risk-treatment paradox in HF & kidney disease, such that pts with the highest mortality are treated with ↓ disease-modifying Rx Supported by @AHAScience & @AstraZeneca https://t.co/9dtLNLdVZu https://t.co/VSFp8tXBlR